Insider · CIK 0002014348
Kendall A Kowalski
officer
Files at HBAN (HUNTINGTON BANCSHARES INC /MD/). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | HBAN HUNTINGTON BANCSHARES INC /MD/ | AGrant or award Common Stock | +715 | $0.00 | $0 | 70,740 | 6 d ago |
| Oct 1, 2026 | HBAN HUNTINGTON BANCSHARES INC /MD/ | AGrant or award Common Stockindirect: By Issuer's Supplemental Stock Purchase and Tax Savings Plan | +72 | $0.00 | $0 | 6,980 | 6 d ago |
| Mar 26, 2025 | HBAN HUNTINGTON BANCSHARES INC /MD/ | FTax withholding Common Stock | -1,641 | $15.26 | $25k | 95,001 | Mar 28, 2025 |
| Mar 7, 2025 | HBAN HUNTINGTON BANCSHARES INC /MD/ | AGrant or award Common Stock | +22,537 | $0.00 | $0 | 103,483 | Mar 12, 2025 |
| Mar 7, 2025 | HBAN HUNTINGTON BANCSHARES INC /MD/ | FTax withholding Common Stock | -6,841 | $15.14 | $104k | 96,642 | Mar 12, 2025 |
| Mar 3, 2025 | HBAN HUNTINGTON BANCSHARES INC /MD/ | AGrant or award Common Stock | +16,676 | $0.00 | $0 | 80,945 | Mar 5, 2025 |
| Feb 28, 2025 | HBAN HUNTINGTON BANCSHARES INC /MD/ | FTax withholding Common Stock | -2,851 | $16.47 | $47k | 64,269 | Mar 4, 2025 |
| Jan 2, 2025 | HBAN HUNTINGTON BANCSHARES INC /MD/ | AGrant or award Common Stock | +583 | $0.00 | $0 | 67,120 | Jan 6, 2025 |
| Jan 2, 2025 | HBAN HUNTINGTON BANCSHARES INC /MD/ | AGrant or award Common Stockindirect: By Issuer's Supplemental Stock Purchase and Tax Savings Plan | +61 | $0.00 | $0 | 6,534 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.